| PERIOD ENDING | 31-Dec-02 | 31-Dec-01 | 31-Dec-00 | | Total Revenue | 3,231 | 5,309 | 3,002 | | Cost of Revenue | 994 | 1,361 | 2,117 | | | Gross Profit | 2,237 | 3,948 | 885 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,243 | 1,271 | 1,316 | | Non Recurring |
-
| 3,661 |
-
| | Others | 35 | 103 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 959 | (1,087) | (431) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | 46 |
-
| | Earnings Before Interest And Taxes | 976 | (1,041) | (431) | | Interest Expense | 5 | 127 | 229 | | Income Before Tax | 971 | (1,167) | (660) | | Income Tax Expense | (9) | 34 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 980 | (1,201) | (660) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 980 | (1,201) | (660) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $980 | ($1,201) | ($660) |
|
1.52% Nasdaq 0.00%
Income Statement
